Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

PI3K class II α controls spatially restricted endosomal PtdIns3P and Rab11 activation to promote primary cilium function.

Franco I, Gulluni F, Campa CC, Costa C, Margaria JP, Ciraolo E, Martini M, Monteyne D, De Luca E, Germena G, Posor Y, Maffucci T, Marengo S, Haucke V, Falasca M, Perez-Morga D, Boletta A, Merlo GR, Hirsch E.

Dev Cell. 2014 Mar 31;28(6):647-58. doi: 10.1016/j.devcel.2014.01.022.

2.

The trigger-maintenance model of persistent mild to moderate hyperoxaluria induces oxalate accumulation in non-renal tissues.

Marengo SR, Zeise BS, Wilson CG, MacLennan GT, Romani AM.

Urolithiasis. 2013 Nov;41(6):455-66. doi: 10.1007/s00240-013-0584-5. Epub 2013 Jul 3.

PMID:
23821183
3.

Construction of a global pain systems network highlights phospholipid signaling as a regulator of heat nociception.

Neely GG, Rao S, Costigan M, Mair N, Racz I, Milinkeviciute G, Meixner A, Nayanala S, Griffin RS, Belfer I, Dai F, Smith S, Diatchenko L, Marengo S, Haubner BJ, Novatchkova M, Gibson D, Maixner W, Pospisilik JA, Hirsch E, Whishaw IQ, Zimmer A, Gupta V, Sasaki J, Kanaho Y, Sasaki T, Kress M, Woolf CJ, Penninger JM.

PLoS Genet. 2012;8(12):e1003071. doi: 10.1371/journal.pgen.1003071. Epub 2012 Dec 6.

4.

Real-world management of atrial fibrillation in Internal Medicine units: the FADOI 'FALP' observational study.

Campanini M, Frediani R, Artom A, Pinna G, Valerio A, La Regina M, Marengo S, Lo Pinto G, Del Signore E, Bonizzoni E, Mathieu G, Mazzone A, Vescovo G; FALP Study Group.

J Cardiovasc Med (Hagerstown). 2013 Jan;14(1):26-34. doi: 10.2459/JCM.0b013e328348e5ce.

PMID:
21738049
5.

The RacGAP ArhGAP15 is a master negative regulator of neutrophil functions.

Costa C, Germena G, Martin-Conte EL, Molineris I, Bosco E, Marengo S, Azzolino O, Altruda F, Ranieri VM, Hirsch E.

Blood. 2011 Jul 28;118(4):1099-108. doi: 10.1182/blood-2010-12-324756. Epub 2011 May 6.

6.

The absence of functional PI3Kgamma prevents leukocyte recruitment and ameliorates DSS-induced colitis in mice.

van Dop WA, Marengo S, te Velde AA, Ciraolo E, Franco I, ten Kate FJ, Boeckxstaens GE, Hardwick JC, Hommes DW, Hirsch E, van den Brink GR.

Immunol Lett. 2010 Jun 15;131(1):33-9. doi: 10.1016/j.imlet.2010.03.008. Epub 2010 Mar 27.

PMID:
20347874
7.

Partitioning of 14C-oxalate excretion in rats during a persistent oxalate challenge.

Marengo SR, Zhang A, Traverso EJ.

Urol Res. 2008 Dec;36(6):319-26. doi: 10.1007/s00240-008-0155-3. Epub 2008 Oct 16.

PMID:
18923824
8.

Phosphoinositide 3-kinase p110beta activity: key role in metabolism and mammary gland cancer but not development.

Ciraolo E, Iezzi M, Marone R, Marengo S, Curcio C, Costa C, Azzolino O, Gonella C, Rubinetto C, Wu H, Dastrù W, Martin EL, Silengo L, Altruda F, Turco E, Lanzetti L, Musiani P, Rückle T, Rommel C, Backer JM, Forni G, Wymann MP, Hirsch E.

Sci Signal. 2008 Sep 9;1(36):ra3. doi: 10.1126/scisignal.1161577.

9.

Oxalate in renal stone disease: the terminal metabolite that just won't go away.

Marengo SR, Romani AM.

Nat Clin Pract Nephrol. 2008 Jul;4(7):368-77. doi: 10.1038/ncpneph0845. Epub 2008 Jun 3.

PMID:
18523430
10.

Maturing the sperm: unique mechanisms for modifying integral proteins in the sperm plasma membrane.

Marengo SR.

Anim Reprod Sci. 2008 Apr;105(1-2):52-63. doi: 10.1016/j.anireprosci.2007.11.018. Epub 2007 Nov 26. Review.

PMID:
18255240
11.

Intraprostatic lymphocyte profiles in aged wistar rats with estradiol induced prostate inflammation.

Vykhovanets EV, Resnick MI, Marengo SR.

J Urol. 2006 Apr;175(4):1534-40.

PMID:
16516042
12.

Gene expression in the LNCaP human prostate cancer progression model: progression associated expression in vitro corresponds to expression changes associated with prostate cancer progression in vivo.

Chen Q, Watson JT, Marengo SR, Decker KS, Coleman I, Nelson PS, Sikes RA.

Cancer Lett. 2006 Dec 8;244(2):274-88. Epub 2006 Feb 23.

PMID:
16500022
13.

Continuous infusion of oxalate by minipumps induces calcium oxalate nephrocalcinosis.

Marengo SR, Chen DH, Evan AP, Sommer AJ, Stowe NT, Ferguson DG, Resnick MI, MacLennan GT.

Urol Res. 2006 Jun;34(3):200-10. Epub 2006 Feb 15.

PMID:
16479391
14.
15.

Constitutive activation of P I3 K-Akt and NF-kappaB during prostate cancer progression in autochthonous transgenic mouse model.

Shukla S, Maclennan GT, Marengo SR, Resnick MI, Gupta S.

Prostate. 2005 Aug 1;64(3):224-39.

PMID:
15712212
17.
18.

PI3Kgamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects.

Patrucco E, Notte A, Barberis L, Selvetella G, Maffei A, Brancaccio M, Marengo S, Russo G, Azzolino O, Rybalkin SD, Silengo L, Altruda F, Wetzker R, Wymann MP, Lembo G, Hirsch E.

Cell. 2004 Aug 6;118(3):375-87.

19.

Nuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression.

Shukla S, MacLennan GT, Fu P, Patel J, Marengo SR, Resnick MI, Gupta S.

Neoplasia. 2004 Jul-Aug;6(4):390-400.

20.

Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis.

Marengo SR, Chen D, MacLennan GT, Resnick MI, Jacobs GH.

J Urol. 2004 Mar;171(3):1304-8.

PMID:
14767338
21.

Levels of urinary inter-alpha-trypsin inhibitor trimer as a function of age and sex-hormone status in males and females not forming stones.

Ricchiuti V, Hartke DM, Yang LZ, Goldman HB, Elder JS, Resnick MI, Marengo SR.

BJU Int. 2002 Oct;90(6):513-7.

22.
23.

Urological medical malpractice.

Kahan SE, Goldman HB, Marengo S, Resnick MI.

J Urol. 2001 May;165(5):1638-42.

PMID:
11342944
24.

Expression of proteins that inhibit calcium oxalate crystallization in vitro in the urine of normal and stone-forming individuals.

Hedgepeth RC, Yang L, Resnick MI, Marengo SR.

Am J Kidney Dis. 2001 Jan;37(1):104-112.

PMID:
11136174
25.

Analysis of the murine phosphoinositide 3-kinase gamma gene.

Hirsch E, Wymann MP, Patrucco E, Tolosano E, Bulgarelli-Leva G, Marengo S, Rocchi M, Altruda F.

Gene. 2000 Oct 3;256(1-2):69-81.

PMID:
11054537
26.

Chemoprevention of prostate carcinogenesis by alpha-difluoromethylornithine in TRAMP mice.

Gupta S, Ahmad N, Marengo SR, MacLennan GT, Greenberg NM, Mukhtar H.

Cancer Res. 2000 Sep 15;60(18):5125-33.

27.

Expression of prolactin and prolactin receptors by non-Hodgkin's lymphoma cells.

Matera L, Geuna M, Pastore C, Buttiglieri S, Gaidano G, Savarino A, Marengo S, Vonderhaar BK.

Int J Cancer. 2000 Jan 1;85(1):124-30.

28.

A new human prostate carcinoma cell line, 22Rv1.

Sramkoski RM, Pretlow TG 2nd, Giaconia JM, Pretlow TP, Schwartz S, Sy MS, Marengo SR, Rhim JS, Zhang D, Jacobberger JW.

In Vitro Cell Dev Biol Anim. 1999 Jul-Aug;35(7):403-9.

PMID:
10462204
29.

Overexpression of ornithine decarboxylase in prostate cancer and prostatic fluid in humans.

Mohan RR, Challa A, Gupta S, Bostwick DG, Ahmad N, Agarwal R, Marengo SR, Amini SB, Paras F, MacLennan GT, Resnick MI, Mukhtar H.

Clin Cancer Res. 1999 Jan;5(1):143-7.

30.
31.
32.

Metastasis induced by overexpression of p185neu-T after orthotopic injection into a prostatic epithelial cell line (NbE).

Marengo SR, Sikes RA, Anezinis P, Chang SM, Chung LW.

Mol Carcinog. 1997 Jul;19(3):165-75.

PMID:
9254883
33.

Effects of recombinant human megakaryocyte growth and development factor on platelet activation.

Montrucchio G, Brizzi MF, Calosso G, Marengo S, Pegoraro L, Camussi G.

Blood. 1996 Apr 1;87(7):2762-8.

35.

Synthesis and photodynamic activities of silicon 2,3-naphthalocyanine derivatives.

Brasseur N, Nguyen TL, Langlois R, Ouellet R, Marengo S, Houde D, van Lier JE.

J Med Chem. 1994 Feb 4;37(3):415-20.

PMID:
8308868
36.
37.
38.

Supplemental Content

Loading ...
Support Center